SYNTHOS RESEARCH

Roblox RBLX

Technology · Electronic Gaming & Multimedia · Synthos Deep Dive · 2026-08-04

$36.67
Stage-In (deep-value, high-uncertainty) — the stock is down 74.1% from its high and sits 3.0% off its 52-week low with RSI at 23.4, while the business just grew revenue 35.9% year over year, narrowed its operating margin from -29.8% to -15.6%, generated $1.353B of free cash flow at a 27.7% margin, and holds $1.25B of net cash. At roughly 18x free cash flow that is a genuine dislocation. It is staged rather than full-size because this dataset contains NO explanation for a 74% drawdown, and an unexplained collapse of that magnitude is a reason for humility, not conviction.

The Overview

Roblox runs a platform where users — mostly young ones — build and play three-dimensional games and experiences made by other users. It makes money selling a virtual currency that players spend inside those experiences, sharing the proceeds with the creators.

The business, as reported, is doing well. Revenue grew about 36% in the most recent quarter. It loses money on paper, but the loss is shrinking fast — down from $322 million to $229 million in a year, while revenue grew a third. More importantly, it generates real cash: about $1.35 billion of free cash flow last year, more than double the year before. It has more cash than debt, and it holds $4.2 billion of money customers have already paid but that has not yet been counted as revenue.

And yet the stock has fallen 74% from its high, and sits within 3% of its lowest point in a year.

That gap is the whole issue. When the reported numbers get better and the share price falls by three-quarters, one of two things is happening: either the market has made a mistake, or the market is reacting to something that does not appear in the financial statements. We cannot tell which from the data we have. There is no news, no regulatory information, no competitive analysis in this dataset — only the numbers, and the numbers look good.

What we can say precisely: at today's price you are paying roughly 18 times last year's free cash flow for a business growing over 35%, with more cash than debt. If nothing is fundamentally broken, that is cheap. If something is broken and we cannot see it, it is not.

Our answer is to buy a small position rather than a full one — enough to participate if this is a mistake, small enough that being wrong about an invisible risk does not matter much.


Putting a number on it: our fair-value estimate is $43 against a current price of $36.67 — real upside if our numbers are right.

Our summary metrics

Downside Risk (lower = safer)
7/10 · High
The financial risk is low and the interpretive risk is very high. Financially — $1.205B cash plus $1.850B short-term investments against $1.803B total debt gives $1.252B of NET CASH (my computation), free cash flow of $1.353B, and a 6.3% free-cash-flow yield. Do NOT read leverage from the vendor ratios: a 12.08x debt-to-equity and a 172.9x price-to-book are arithmetic artefacts of a $394.5M equity base compressed by a $5.06B accumulated deficit and $4.17B of deferred revenue sitting in current liabilities; the 0.82 current ratio has the same cause and is not a liquidity signal. The real risks are: (a) a 74.1% drawdown whose cause is NOT in this file — no regulatory, safety, competitive or guidance information is available here; (b) consensus models GAAP losses every year through FY29, with profitability only in FY30; (c) stock compensation is 20.1% of revenue; (d) beta 1.414 with a -73.4% twelve-month return. Rated 7 — the balance sheet is sound and the cash flow is real, but underwriting an unexplained 74% decline is genuinely risky and we will not pretend otherwise.
Growth Quality
8/10 · Very High
Excellent and, importantly, still accelerating at the margin. FY25 revenue $4.891B (+35.8%); Q1 2026 $1.442B (+39.3%); Q2 2026 $1.469B (+35.9%). Gross margin 78.1%. Free cash flow $1.353B in FY25 against $641.3M in FY24, a 111% increase, at a 27.7% margin. Deferred revenue $4.169B (+38.7%), growing faster than revenue — customers are prepaying at an accelerating rate. And the operating loss is narrowing in absolute terms while revenue grows 36%: -$322.5M in Q2 2025 became -$229.0M in Q2 2026, i.e. margin improved 14.3 percentage points in a year. That combination — high growth, improving unit economics, growing prepayments — is what growth quality looks like. Capped at 8 because it remains GAAP loss-making with no consensus profitability until FY30.
Exponential Potential
7/10 · High
One of the two highest exponential scores in this batch, and the most credible. Five knowledge-base claims describe a genuine compounding asset: 13 billion hours per month of 3D vector interaction data that is reproducible from any camera angle and uniquely suited to training world models and non-player characters; a creator economy where top creators earn tens of millions annually and the long tail is growing faster than the top; and a native code assistant plus environmental-generation engine inside the creation tool. Data that compounds with usage, feeding models that improve the product that generates more data, is a real flywheel. Marked 7 rather than 8-9 because all five claims come from a single half-weighted source, and because none of the exponential potential has yet shown up as GAAP profit.
Fair value$43 $22–$64
What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, We don’t publish a reverse-DCF cross-check for pre-profit companies — negative or missing earnings break that math — so take this number on our modeling alone.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

The Road Ahead

What we expect to matter in each window, and the evidence that would prove us wrong.

Short term 0-6 months

Neutral
Driver
$36.67 sits 74.1% below the $141.56 52-week high and only 3.0% above the $35.60 low, far below both a falling 50-DMA ($48.79) and a falling 200-DMA ($69.40), with RSI at 23.4 (deeply oversold) and MACD at -2.42. Every trend measure is negative and the stock is pinned to its low. This is either the point of maximum pessimism or the middle of a repricing that has further to run — and, honestly, the data in this file cannot distinguish between them. The one positive: the Q2 print on 2026-07-30 beat consensus EPS (-$0.26 against -$0.344) and the stock is still here, which suggests the market is not trading on the reported quarter.
What we’re watching
Whether $35.60 (the 52-week low, 3% below spot) holds. Below it there is no reference point in this dataset. Also watch for any insider PURCHASE — three officers and directors sold between $55.77 and $58.03 in early July, roughly 50-58% above today's price, and a purchase at these levels by anyone would be the single most informative signal available.

Medium term 6-24 months

Tailwind
Driver
The cash-flow trajectory is the case. FY25 free cash flow of $1.353B on a $26.20B market cap is a 5.2% yield, and at an enterprise value of $24.94B it is roughly 18x. If the operating-margin improvement continues at anything like the 14.3-point annual rate just delivered, GAAP breakeven arrives well before the FY30 consensus implies, and the earnings-based multiple stops being meaningless. Deferred revenue of $4.169B growing 38.7% funds the runway.
What we’re watching
Whether the operating loss keeps narrowing in absolute terms (-$322.5M → -$229.0M year over year in Q2); free cash flow versus the FY25 $1.353B base; deferred revenue growth staying above 30%; stock compensation as a share of revenue (currently 20.1%); and the diluted share count, which has grown from 642.8M to 716.8M in two years — a 3.6% annual dilution that the market is not currently being compensated for.

Long term 2+ years

Tailwind
Driver
The strongest long-run asset in this batch on the knowledge-base evidence: 13 billion hours per month of three-dimensional vector interaction data — not video frames, but the underlying scene geometry, reproducible from any camera angle — which is materially more valuable for training world models and non-player-character behaviour than any equivalent corpus. Combined with a creator economy in which top creators earn tens of millions annually and the long tail is growing faster than the leaders, this is a compounding asset that competitors cannot buy.
What we’re watching
Whether the data asset converts into a distinct revenue line rather than remaining a product-quality input; whether the creator economy's long tail keeps outgrowing the head (a health signal for platform vitality); competitive entry from the larger platform owners; and whether the regulatory and safety environment — entirely absent from this dataset and a plausible candidate for the missing explanation of the drawdown — resolves.

Exponential Potential

Exponential Potential
7/10 · High
One of the two highest exponential scores in this batch, and the most credible. Five knowledge-base claims describe a genuine compounding asset: 13 billion hours per month of 3D vector interaction data that is reproducible from any camera angle and uniquely suited to training world models and non-player characters; a creator economy where top creators earn tens of millions annually and the long tail is growing faster than the top; and a native code assistant plus environmental-generation engine inside the creation tool. Data that compounds with usage, feeding models that improve the product that generates more data, is a real flywheel. Marked 7 rather than 8-9 because all five claims come from a single half-weighted source, and because none of the exponential potential has yet shown up as GAAP profit.

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.


Reference table

Street consensus$49.47 (median $46, high $95, low $30) · 16 buy / 18 hold / 3 sell — consensus rating is Hold
ValuationGAAP loss-making · EV/free cash flow ~18.4x · EV/TTM GAAP sales 4.39x · free-cash-flow yield 6.3% · price-to-earnings meaningless
ConvictionLow-Moderate — 9 KB claims, but the 5 substantive ones are all from one source on one date and are half-weighted as management/guest framing
TechnicalsMaximum pessimism — -74.1% from the high, +3.0% off the 52-week low, RSI 23.4, below a falling 50-DMA ($48.79) and 200-DMA ($69.40)
Position sizingHigh-uncertainty / dislocation sleeve. 1.5-2.5% target, built in 3 tranches. Sized below a normal position because the drawdown is unexplained.

What the experts actually said

No independent expert claims in the Synthos knowledge base yet for RBLX — this dive is fundamentals- and technicals-driven, not panel-driven.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

275889119150Aug '25Oct '25Dec '25Mar '26May '26Aug '2652w hi $142200-DMA 6950-DMA 49Price 3752w lo $36

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Data summary: last close $37.30, 23% below the 50-day average ($49), 46% below the 200-day average ($69) — a downtrend. 74% below the 52-week high of $142, 5% above the 52-week low of $36.

Bollinger Bands 20-day average ± 2 standard deviations

265992124157Aug '25Oct '25Dec '25Mar '26May '26Aug '2620-day avg 50Price 37

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

Data summary: price $37.30 is currently inside the band (band $37–$62).

RSI (14) momentum gauge · 0–100

705030Aug '25Oct '25Dec '25Mar '26May '26Aug '26RSI 30.6

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 31.

MACD 12 / 26 / 9 · trend & momentum

0Aug '25Oct '25Dec '25Mar '26May '26Aug '26signal -1.1MACD -3.0

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Data summary: MACD is currently below its signal line by 1.91, negative momentum.

Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago

175389125161Aug '25Oct '25Dec '25Mar '26May '26Aug '26XLK (sector) 140S&P 500 121RBLX 29

Solid = RBLX · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

0481215$3BFY23EPS $-2$4BFY24EPS $-2$7BFY25EPS $-2$7BFY26EEPS $-1$8BFY27EEPS $-1$10BFY28EEPS $-1$12BFY29EEPS $-0$14BFY30EEPS $0

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$36.67
Market cap$26B
P/E trailingn/m (loss-making or n/a)
P/E FY26E / FY27En/m (loss-making or n/a) / n/m (loss-making or n/a)
EV / Sales4.4×*
EV / EBITDA-31.8×*
Gross margin78.9%
Net margin-17.6%
Dividend yield0.00%
Beta1.414
52-wk range$36 – $142
RSI(14)23
50 / 200-DMA$49 / $69
12-mo return+-73% (SPY +20%)
Street target$49 ($30–$95)
Analyst grades16 Buy · 18 Hold · 3 Sell
FMP ratingC-
Next earnings2026-10-29 (Q3 2026 earnings; consensus EPS -$0.423, revenue estimate $1.664B — note this estimate is on a MIXED basis and is not comparable to the $1.469B GAAP revenue just reported; see section 4)

* Enterprise value recomputed in-house: the data vendor nets cash but omits short-term investments, overstating EV for cash-rich balance sheets. EV multiples marked * use market cap + total debt − cash − short-term investments.

1. Data integrity — three problems in this file, and they must come first

This is one of the more compromised files in the batch and the reader needs the caveats before the analysis, not after.

(a) REJECTED — the entire consensus EBITDA series. The estimate block reports negative ebitdaAvg in every forecast year: -$1.771B (FY26E), -$2.032B (FY27E), -$2.396B (FY28E), -$3.028B (FY29E), -$3.389B (FY30E) — a figure that grows more negative every year while the same rows show netIncomeAvg turning positive at +$179.3M in FY30. A company cannot have EBITDA of -$3.39B and net income of +$179M in the same year. The series is internally impossible. No EBITDA-based multiple appears anywhere in this dive. This same failure mode appears in several other files in this batch and looks systematic rather than company-specific.

(b) FLAGGED — the estimate revenue series is on a DIFFERENT BASIS from reported GAAP revenue, and the earnings calendar switches between them mid-series. This is subtle and it invalidates the most obvious comparison an investor would make.

The most likely explanation is that the estimate and recent-calendar series are on a bookings basis — the gross cash value of virtual-currency purchases, which for this business model is recognised as revenue over an extended period and therefore substantially exceeds GAAP revenue. That is a standard metric for this company type. But whatever the label, the practical consequence is unambiguous: do not compare consensus revenue to reported revenue, and do not compute EV/sales using the estimate series. Every revenue multiple in this dive uses reported GAAP revenue and says so.

(c) FLAGGED — segment and geographic disclosure are entirely absent. seg_prod and seg_geo are both empty. For a platform business whose economics depend on regional mix, age-cohort mix and the split between platform revenue and advertising, this is a substantial gap. We have no geographic revenue split, no user metrics, no daily-active-user figure, no bookings-per-user, no age-demographic disclosure. For a company where the bear case most plausibly involves regulation or user safety in specific jurisdictions, the absence of any geographic data is exactly the wrong gap to have.

(d) DO NOT MISREAD — the leverage and book-value ratios. The vendor reports debtToEquityRatioTTM of 12.08, priceToBookRatioTTM of 172.9 and currentRatioTTM of 0.82. Read naively these describe a distressed, over-levered company. They describe nothing of the kind. Shareholders' equity is only $394.5M because the balance sheet carries a -$5.061B accumulated deficit and $4.169B of deferred revenue sitting in current liabilities. Recomputing by hand from the balance sheet: cash $1.205B + short-term investments $1.850B − total debt $1.803B = $1.252B of NET CASH. The current ratio of 0.82 is caused by deferred revenue — an obligation to deliver a service, not to pay cash — being classified as a current liability. This company has no leverage problem. We flag this specifically because these are exactly the ratios a screen would flag as distress.

CHECKED AND CLEAN — the most recent quarter. inc_q[0] (Q2 2026, 2026-06-30) passes the standard screen: net income -$183M against 716.767M shares gives -$0.255 versus the reported -$0.26; share counts do not duplicate the prior quarter (716.767M against 711.697M) and continue a steady upward trend; interest expense of $10M is consistent with every prior quarter; the reported EPS matches the earnings-calendar actual of -$0.26 exactly. The quarter is usable.

2. What the operating numbers actually say

Annual record:

FY22FY23FY24FY25
Revenue (GAAP)$2.225B$2.799B$3.602B$4.891B
Growth+25.8%+28.7%+35.8%
Gross margin75.4%76.8%77.8%78.1%
R&D$873.5M$1.254B$1.444B$1.568B
Operating income-$923.8M-$1.259B-$1.063B-$1.232B
Net income-$924.4M-$1.152B-$935.4M-$1.065B
Operating cash flow$369.3M$458.2M$822.3M$1.796B
Capex-$427.7M-$334.2M-$181.0M-$443.5M
Free cash flow-$58.4M$124.0M$641.3M$1.353B
Stock compensation$589.5M$868.0M$1.016B$1.129B

Revenue growth has ACCELERATED for three consecutive years — 25.8%, 28.7%, 35.8% — while gross margin expanded every year. Free cash flow has gone from negative to $1.353B in three years. These are not the financials of a business in trouble.

Quarterly record — where the margin improvement shows:

QuarterRevenueYoYOperating incomeOp marginNet incomeEPSvs consensus
Q2 2024$893.5M-$237.9M-26.6%-$205.9M-$0.32
Q3 2024$919.0M-$278.9M-30.4%-$239.3M-$0.37
Q4 2024$988.2M-$244.1M-24.7%-$219.6M-$0.33
Q1 2025$1,035.0M-$255.0M-24.6%-$215.0M-$0.32
Q2 2025$1,080.7M+21.0%-$322.5M-29.8%-$278.4M-$0.41Miss
Q3 2025$1,359.6M+48.0%-$296.5M-21.8%-$255.6M-$0.37Beat
Q4 2025$1,415.0M+43.2%-$358.6M-25.3%-$316.0M-$0.45Beat
Q1 2026$1,442.0M+39.3%-$294.0M-20.4%-$246.0M-$0.35Beat
Q2 2026$1,469.0M+35.9%-$229.0M-15.6%-$183.0M-$0.26Beat

Read the last row against the row four above it. Q2 2025: revenue $1,080.7M, operating loss $322.5M, margin -29.8%. Q2 2026: revenue $1,469.0M (+35.9%), operating loss $229.0M (a $93.5M reduction in absolute dollars), margin -15.6%. The company grew revenue 36% and simultaneously cut its operating loss by 29% in absolute terms. That is a 14.3-percentage-point margin improvement in twelve months, and it is the single strongest operating fact in this dive.

Four consecutive earnings beats. The most recent (2026-07-30) came in at -$0.26 against a -$0.344 consensus — a 24% beat. And the stock is 3% off its 52-week low.

Deferred revenue rose from $3.005B (FY24) to $4.169B (FY25), +38.7% — faster than revenue growth. This is cash already received against future delivery. Customers are prepaying at an accelerating rate, which is difficult to reconcile with any thesis of user abandonment.

3. Balance sheet and cash generation

Balance sheet (FY25, 2025-12-31):

Cash generation is the core of the investment case:

The dilution caveat. Diluted shares have grown from 642.8M (Q2 2024) to 716.8M (Q2 2026)+11.5% in two years, roughly 5.5% annually. There is no buyback (commonStockRepurchased is $0 in every year on file) and net stock issuance is positive. A shareholder's claim on that $1.353B of free cash flow is shrinking by roughly 5% a year. With $1.25B of net cash and a share price at $36.67, a buyback would be highly accretive; management has not initiated one, and that is a legitimate criticism.

4. The drawdown — what we can and cannot say

The facts: $36.67 against a 52-week high of $141.56 — -74.1%. Twelve-month return -73.4% against SPY's +19.9% and QQQ's +23.9%, a 93-point relative deficit. Three-month return -18.7%. The stock is 3.0% above its 52-week low of $35.60. RSI 23.4. MACD -2.42. Both moving averages are falling and price is 47% below the 200-DMA.

A minor data inconsistency: the profile block reports a 52-week range of $33.88-$142.00 while the technical block reports $35.60-$141.56. The conclusion is unaffected.

What this file does NOT contain, and what we therefore cannot assess: any news, regulatory filing, safety or child-protection development, litigation, competitive entry, management guidance, user metric, or analyst commentary. There is no field in this dataset that explains a 74% decline.

What we can rule out from the data available:

What remains as candidate explanations, none verifiable here: a regulatory or child-safety development (the most commonly cited structural risk for this business model, and one that would not appear in any financial field); a guidance cut for periods beyond the estimate horizon in this file; a change in the bookings-to-revenue relationship; a broad de-rating of high-multiple growth names; or forced selling.

The intellectually honest position: we are looking at a large, quantifiable dislocation between price and reported operating performance, and we do not know its cause. That is a reason to take a position, because the arithmetic is compelling. It is equally a reason to take a small one, because an unexplained 74% decline usually has an explanation. Every element of the verdict — Stage-In rather than Buy, 1.5-2.5% rather than 3-5%, three tranches rather than one — follows from that single sentence.

5. Knowledge base — bullish, narrow, half-weighted, and silent on the bear case

Nine claims match this company. Five are substantive — and all five come from a SINGLE source on a SINGLE date (no_priors, 2026-02-05):

These are half-weighted, and the reason is important. The framing is unmistakably first-person company language — "Roblox's 20-year vision", a company operating principle stated as a maxim, internal product-roadmap detail about what agents will do. Under the house rule on management framing, claims sourced from company voices carry half weight. We flag this rather than counting five high-conviction claims at face value, and it is the single largest reason the conviction rating is Low-Moderate rather than High despite an average conviction of 74 across the substantive claims.

Four further claims are tangential and add breadth without content:

The most important observation about this entire lane: not one claim addresses the bear case. There is nothing in the knowledge base about regulation, child safety, user-growth deceleration, competitive pressure, or valuation. The panel's coverage of this name is a product and technology lane, dated February 2026, before the bulk of the decline. It tells us the asset is interesting. It tells us nothing about why the stock fell 74%. Presenting it as conviction support for buying the dip would be a misuse of it, and we decline to do that.

6. Valuation — priced in or room?

At $36.67 (market cap $26.196B, net cash $1.252B, EV $24.94B):

MetricValueBasis
EV / FY25 free cash flow18.4x$24.94B ÷ $1.353B
EV / TTM GAAP revenue4.39x$24.94B ÷ $5.686B (last four reported quarters)
EV / FY25 GAAP revenue5.10x$24.94B ÷ $4.891B
Free-cash-flow yield (market cap)5.2%$1.353B ÷ $26.196B
Price / earningsnot meaningfulGAAP loss-making
Price / book172.9x — meaninglesssee section 1(d)

Consensus (with the basis caveat from section 1(b) applying to every revenue figure):

FY26EFY27EFY28EFY29EFY30E
Revenue (mixed/bookings basis)$7.156B$8.209B$9.683B$12.234B$13.691B
EPS-$1.452-$1.149-$0.931-$0.418+$0.26
Analyst count (EPS)151915106
EBITDAREJECTEDREJECTEDREJECTEDREJECTEDREJECTED

Consensus does not model GAAP profitability until FY30. That is four and a half years away and it is the central reason this stock carries no earnings-based support.

6a. What today's price assumes (the inversion)

At $36.67 — approximately 18.4x trailing free cash flow and 4.39x trailing GAAP revenue — the price embeds the following falsifiable claims:

The single most fragile assumption: that the operating-margin improvement stops. Q2 2026 delivered a 14.3-point year-over-year margin gain and a $93.5M absolute reduction in operating loss on 36% revenue growth. Consensus models losses persisting for four more years. One of those two things is wrong, and the reported quarter is the one with evidence behind it.

6b. The return bridge (why the multiple moves)

Expected return ≈ free-cash-flow growth + multiple drift + shareholder yield. We use free cash flow rather than EPS because there are no earnings.

The bridge reads: solid free-cash-flow growth, plus assumed multiple normalisation, less ~5% annual dilution. Net approximately +18% to our base case. The dilution term is why the base case is $43 rather than $46.

Scenario bands (stated arithmetic, no DCF):

Base sits 18% above spot and 13% below the $49.47 street consensus. We are more cautious than the sell-side, principally because of the dilution drag and because we discount for the information we do not have.

6c. Variant perception (where we differ, what would surprise)

7. Moat and competitive position

The moat has three layers, and the knowledge base describes all three.

The creator economy. Roblox does not make the content; users do, and they are paid for it. The knowledge base records that top creators earn tens of millions of dollars annually, and — the more important detail — that long-tail creator revenue is growing faster than the top creator's. A creator ecosystem where the tail grows faster than the head is a healthy one: it means opportunity is widening rather than concentrating, which is what keeps new creators arriving. This is a two-sided network that a competitor cannot buy.

The data asset. The strongest claim in the lane: 13 billion hours per month of three-dimensional vector interaction data — scene geometry rather than rendered video, reproducible from any camera angle. For training world models and non-player-character behaviour that is a materially more useful corpus than video, because it contains the underlying structure rather than a projection of it. No competitor has an equivalent, and the asset compounds with usage.

Switching costs. Users' social graphs, purchased items, creations and reputations live on the platform. For the core cohort these are not transferable.

Where the moat is weakest. The business is concentrated in a demographic that ages out, so cohort replacement is a permanent requirement. The 78.1% gross margin is struck after creator payouts, so the economics depend on a revenue-share that competitors could bid against. And — the honest gap — with no user metrics, no geographic split and no age-cohort disclosure in this file, we cannot verify that the moat is holding. We are inferring platform health from revenue growth and deferred revenue, which are good proxies but not direct evidence.

The vendor's assigned peer set (CoreWeave, Electronic Arts, Fortinet, Corning, Infosys, Motorola Solutions, Strategy, NetEase, TE Connectivity, Take-Two) is a market-capitalisation cohort rather than a competitive set. The only genuinely comparable names in it are Electronic Arts ($52.98B) and Take-Two ($45.84B) — both traditional publishers with fundamentally different economics, and both carrying market capitalisations roughly twice Roblox's on materially slower growth.

8. Insider activity

The record shows three sellers and no buyers, all in early July 2026:

DateInsiderRoleSharesPrice
2026-07-01Gregory Baszuckidirector650$55.97
2026-07-01""2,250$57.36
2026-07-01""5,433$58.03
2026-07-01""650$55.97 (separate holding)
2026-07-06Mark ReinstraChief Legal Officer & Corporate Secretary200$55.77
2026-07-06""3,212$57.24
2026-07-06""1,100$57.94
2026-07-14Amy Marie RawlingsChief Accounting Officer6,567 (A-Award)$0

Two observations, and the second is the one that matters.

First, the sales are small — roughly 8,300 shares by Baszucki (a director, retaining 8,969,734 shares in one holding plus 1,285,518 in another) and roughly 4,500 by Reinstra (retaining 422,248). These are trivial fractions of very large positions and carry little signal. The Rawlings transaction is an equity award, not a sale.

Second, and materially: every one of those sales was executed between $55.77 and $58.03 — that is 52% to 58% ABOVE today's price of $36.67. The stock has fallen roughly 35% in the four weeks since. These insiders did not sell into a top; they sold into what has turned out to be the beginning of a further collapse. That tells us the decline was not anticipated by the people best placed to anticipate it — which is mild evidence against the hypothesis that a known company-specific problem drove the fall, and mild evidence for the dislocation reading.

And there are no purchases. With the stock 74% off its high and $1.25B of net cash on the balance sheet, the absence of a single insider buy — and of any buyback — is the most conspicuous gap in the entire file.

9. Verdict, kill-criteria and flip conditions

Stage-In (deep-value, high-uncertainty). At $36.67 Roblox trades at roughly 18.4x trailing free cash flow and 4.39x trailing GAAP revenue, with $1.25B of net cash, against a business that grew revenue 35.9% in the quarter just reported, improved operating margin by 14.3 percentage points year over year, generated $1.353B of free cash flow at a 27.7% margin (more than double the prior year), grew deferred revenue 38.7%, and beat consensus in each of its last four prints. Our base fair value of $43 is 18% above spot; the street's is $49.47.

Three reasons this is staged rather than full-size, each falsifiable:

1. This dataset contains no explanation for a 74.1% decline. Not one financial line deteriorated. An unexplained collapse of that magnitude usually has a cause, and we cannot see it. Sizing is the only honest response to an information gap of this size.

2. The knowledge-base lane, though bullish, is silent on the bear case — five substantive claims, all from one source on one date in February 2026, all in company-vision framing and therefore half-weighted, none addressing regulation, safety, competition or valuation.

3. Shareholder yield is negative — roughly 5% annual dilution with no buyback, despite $1.25B of net cash and a 74% drawdown. That is a real drag and a real criticism of capital allocation.

Staged entry — build a 1.5-2.5% position in three tranches:

1. Tranche 1 — now (~1/3 of target), at ~$37. RSI 23.4, 3% off the 52-week low, ~18x free cash flow, net cash, four consecutive beats. You are buying the arithmetic, deliberately small.

2. Tranche 2 — the reaction to the 2026-10-29 print. Add on a third consecutive quarter of absolute operating-loss reduction with revenue growth above 30%. If the loss widens or growth falls below 25%, do not add.

3. Tranche 3 — either a reclaim of the 50-DMA (~$49) on volume, confirming a trend change, or a capitulation below $30 where the bear case is close to fully priced. Whichever comes first.

Pre-registered KILL criteria (any one converts Stage-In → Avoid, and stops further tranches):

Pre-registered FLIP TO HIGH-CONVICTION (upsize toward 3-4%):

Where RBLX fits in the Synthos Framework Portfolio. A high-uncertainty / dislocation sleeve position at 1.5-2.5%, explicitly below a normal weight. It is not an AI-infrastructure holding and should not be sized as one; the AI angle here is a data asset that may compound, not a revenue line that does. Logged as a tracked Synthos call (Stage-In) as of 2026-08-04 at $36.67.

Single biggest risk: that the market knows something this file does not. Revenue accelerated, margins improved 14 points, cash flow doubled, and the stock fell 74%. Either that is one of the larger mispricings available, or there is an input we cannot see. The entire position-sizing discipline in this dive exists because we cannot distinguish between those two possibilities from the data provided.

Most fragile assumption in the price: that the operating-margin improvement stops. Consensus requires GAAP losses through FY29. The most recently reported quarter cut the absolute operating loss by $93.5M while growing revenue 36%. Those two statements cannot both survive another four quarters, and the resolution — in either direction — is the single largest determinant of what this stock is worth.


Provenance & disclosures